BIO vs. SCHG
Compare and contrast key facts about Bio-Rad Laboratories, Inc. (BIO) and Schwab U.S. Large-Cap Growth ETF (SCHG).
SCHG is a passively managed fund by Charles Schwab that tracks the performance of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. It was launched on Dec 11, 2009.
Performance
BIO vs. SCHG - Performance Comparison
Loading graphics...
BIO vs. SCHG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIO Bio-Rad Laboratories, Inc. | -8.13% | -7.77% | 1.74% | -23.21% | -44.35% | 29.61% | 57.54% | 59.34% | -2.70% | 30.94% |
SCHG Schwab U.S. Large-Cap Growth ETF | -9.73% | 17.50% | 34.95% | 50.10% | -31.80% | 28.11% | 39.14% | 36.02% | -1.36% | 28.05% |
Returns By Period
In the year-to-date period, BIO achieves a -8.13% return, which is significantly higher than SCHG's -9.73% return. Over the past 10 years, BIO has underperformed SCHG with an annualized return of 7.16%, while SCHG has yielded a comparatively higher 16.95% annualized return.
BIO
- 1D
- -0.14%
- 1M
- -0.44%
- YTD
- -8.13%
- 6M
- -6.57%
- 1Y
- 15.98%
- 3Y*
- -16.55%
- 5Y*
- -13.65%
- 10Y*
- 7.16%
SCHG
- 1D
- 0.96%
- 1M
- -4.46%
- YTD
- -9.73%
- 6M
- -8.15%
- 1Y
- 17.00%
- 3Y*
- 22.30%
- 5Y*
- 12.76%
- 10Y*
- 16.95%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIO vs. SCHG — Risk / Return Rank
BIO
SCHG
BIO vs. SCHG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and Schwab U.S. Large-Cap Growth ETF (SCHG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BIO | SCHG | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.37 | 0.76 | -0.39 |
Sortino ratioReturn per unit of downside risk | 0.89 | 1.24 | -0.35 |
Omega ratioGain probability vs. loss probability | 1.11 | 1.17 | -0.06 |
Calmar ratioReturn relative to maximum drawdown | 0.58 | 1.09 | -0.51 |
Martin ratioReturn relative to average drawdown | 1.41 | 3.71 | -2.29 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BIO | SCHG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.37 | 0.76 | -0.39 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.38 | 0.57 | -0.95 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.21 | 0.79 | -0.58 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.26 | 0.79 | -0.53 |
Correlation
The correlation between BIO and SCHG is 0.54, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
BIO vs. SCHG - Dividend Comparison
BIO has not paid dividends to shareholders, while SCHG's dividend yield for the trailing twelve months is around 0.43%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIO Bio-Rad Laboratories, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SCHG Schwab U.S. Large-Cap Growth ETF | 0.43% | 0.36% | 0.39% | 0.46% | 0.55% | 0.42% | 0.52% | 0.82% | 1.27% | 1.01% | 1.04% | 1.22% |
Drawdowns
BIO vs. SCHG - Drawdown Comparison
The maximum BIO drawdown since its inception was -83.64%, which is greater than SCHG's maximum drawdown of -34.59%. Use the drawdown chart below to compare losses from any high point for BIO and SCHG.
Loading graphics...
Drawdown Indicators
| BIO | SCHG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.64% | -34.59% | -49.05% |
Max Drawdown (1Y)Largest decline over 1 year | -24.49% | -16.41% | -8.08% |
Max Drawdown (5Y)Largest decline over 5 years | -73.77% | -34.59% | -39.18% |
Max Drawdown (10Y)Largest decline over 10 years | -73.77% | -34.59% | -39.18% |
Current DrawdownCurrent decline from peak | -66.29% | -12.51% | -53.78% |
Average DrawdownAverage peak-to-trough decline | -27.59% | -5.22% | -22.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.10% | 4.84% | +5.26% |
Volatility
BIO vs. SCHG - Volatility Comparison
Bio-Rad Laboratories, Inc. (BIO) has a higher volatility of 9.14% compared to Schwab U.S. Large-Cap Growth ETF (SCHG) at 6.77%. This indicates that BIO's price experiences larger fluctuations and is considered to be riskier than SCHG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BIO | SCHG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.14% | 6.77% | +2.37% |
Volatility (6M)Calculated over the trailing 6-month period | 25.57% | 12.54% | +13.03% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.95% | 22.45% | +20.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.30% | 22.31% | +13.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.45% | 21.51% | +11.94% |